These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 5048416

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis.
    Iłzecka J, Stelmasiak Z.
    Neurol Sci; 2003 Nov; 24(4):273-4. PubMed ID: 14658047
    [No Abstract] [Full Text] [Related]

  • 23. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M, Nikolaou C, Rombos A, Boufidou F, Zoga M, Dimitrakopoulos A, Tsoutsou A, Vassilopoulos D.
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function.
    Lulé D, Diekmann V, Kassubek J, Kurt A, Birbaumer N, Ludolph AC, Kraft E.
    Neurorehabil Neural Repair; 2007 Oct; 21(6):518-26. PubMed ID: 17476000
    [Abstract] [Full Text] [Related]

  • 28. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
    [Abstract] [Full Text] [Related]

  • 29. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
    Ryberg H, Söderling AS, Davidsson P, Blennow K, Caidahl K, Persson LI.
    Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Scand J Clin Lab Invest; 2007 Jul; 67(3):264-9. PubMed ID: 17454840
    [Abstract] [Full Text] [Related]

  • 34. Bilirubin and amyotrophic lateral sclerosis.
    Iwasaki Y, Igarashi O, Iwasa Y, Hirano K, Satoh R, Iwamoto K, Kawase Y, Aoyagi J, Ichikawa Y, Kawabe K, Ikeda K.
    Clin Neurol Neurosurg; 2005 Feb; 107(2):160; author reply 161. PubMed ID: 15708236
    [No Abstract] [Full Text] [Related]

  • 35. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L, Logroscino G.
    Neurology; 2008 Jan 15; 70(3):222-5. PubMed ID: 18195267
    [Abstract] [Full Text] [Related]

  • 36. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.
    Siklós L, Engelhardt J, Harati Y, Smith RG, Joó F, Appel SH.
    Ann Neurol; 1996 Feb 15; 39(2):203-16. PubMed ID: 8967752
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis.
    Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G, Hays AP.
    Ann Neurol; 1996 Feb 15; 39(2):158-65. PubMed ID: 8967746
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J, Widl K, Schattauer D, Ludolph AC, Tumani H.
    Neurosci Lett; 2007 Apr 18; 416(3):257-60. PubMed ID: 17368721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.